Doctors reveal that the cost of developing medicine may be much lower than the billions claimed by the pharmaceutical industry, urging for transparency in clinical trial spending.
Medecins Sans Frontieres challenges drug companies to disclose trial costs as they unveil their own spending of 34m for trials of a four-drug combination treatment for drug-resistant TB.
[
add
]
[
|
|
...
]